Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Many different therapies are suggested by guidelines to treat loco-regionally advanced or metastatic G1-G2 neuroendocrine tumors (NETs). However, a precise therapeutic algorithm has not yet been established.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Faggiano A, Di Maio S, Tafuto S, Mocerino C, Di Sarno A,
Keywords: neuroendocrine tumor, medical therapy, sequence of treatments,
Introduction: Chemokine receptor CXCR4 has been shown to signal on mTOR pathway in gastric and renal cancer. CXCR4 interacts with the chemokine CXCL12 to exert proliferative and chemotactic effects.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Sciammarella C
Authors: Sciammarella C, Circelli L, Guadagno E, Tafuto S, Del Basso De Caro M,
Keywords: chemokine, mtor, nets, clinical outcome.,
Introduction: Elios is an Educational Learning Investigational Observational Study.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Tafuto S
Authors: Tafuto S, Faggiano A, Riccardi N, Palmieri G, Tatangelo F,
Keywords: neuroendocrine tumor, epidemiology, ssa ,
Introduction: SSAs have been demonstrated to have antiproliferative effects in ileal NETs. The 2010 WHO NET classification provides a grading score which can be helpful in predicting tumor response to SSA.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Faggiano A
Authors: Faggiano A, Carratù A, Tafuto S, Lastoria S, Von Arx C,
Keywords: NET, SSA, G1, G2, WHO classification,
Introduction: Elios is an Educational Learning Investigational Observational Study.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Tafuto S
Authors: Tafuto S, Faggiano A, Riccardi N, Palmieri G, Tatangelo F,
Keywords: neuroendocrine tumor, epidemiology, SSA,